Long Term Safety and Efficacy From Special Surveillance for Etanercept in Japan
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Rheumatoid Arthritis
Both
Rheumatoid Arthritis
Trial Information
Long Term Safety and Efficacy From Special Surveillance for Etanercept in Japan
Inclusion Criteria:
Inclusion Criteria Patients with rheumatoid arthritis (RA) who fulfill all of the
following
1. Patients who are refractory to the treatment.
2. Patients who have never been treated with Enbrel and in whom its long-term therapy
may be instituted.
3. Patients without a history of or concurrent malignant tumors.
Exclusion Criteria:
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Principal Investigator
Pfizer CT.gov Call Center
Investigator Role:
Study Director
Investigator Affiliation:
Pfizer
Authority:
Japan: Pharmaceuticals and Medical Devices Agency
Study ID:
0881A1-4426
NCT ID:
NCT00503139
Start Date:
June 2007
Completion Date:
June 2013
Related Keywords:
- Rheumatoid Arthritis
- Arthritis
- Arthritis, Rheumatoid
Name | Location |
|---|
